Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] Samsung Electronics (005930) – Other Management Matters (Voluntary Disclosure) / 2025-10-30

Posted on October 30, 2025July 29, 2026 By K-STOCK Editor No Comments on [Disclosure] Samsung Electronics (005930) – Other Management Matters (Voluntary Disclosure) / 2025-10-30

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Samsung Electronics has decided to contribute KRW 1.15B in donations to the Korea Association of Athletics Federations to support domestic and international athletic competitions and training expenses.

📊 [Key Disclosure Details & Financial Summary]

  • Disclosure Title: Donation Contribution to Korea Association of Athletics Federations
  • Recipient Entity: Korea Association of Athletics Federations
  • Donation Amount: KRW 1,150,000,000 (Approx. KRW 1.15B)
  • Purpose of Contribution: Hosting and participating in domestic/international athletics competitions, and funding domestic/international training expenses
  • Board Resolution Date: 2025-10-30

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Remittance Execution and Reflection in Periodic Reports

This voluntary disclosure reports the decision to contribute sports sponsorship donations to the Korea Association of Athletics Federations. Verifying whether the committed KRW 1.15B donation is fully executed without delay is important for tracking the implementation progress of this contribution. Related execution details can be verified in future periodic business reports or relevant follow-up disclosures.

📢 Disclaimer & Source Information

Source: This content was newly structured and generated based on official submission data from the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).

Investment Risk Warning: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial liabilities rest entirely with the individual investor.

Contact: For compliance inquiries or copyright concerns, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Semiconductors

Post navigation

Previous Post: [Disclosure] Samsung Electronics (005930) – (Correction) Provisional Consolidated Financial Results (Fair Disclosure) / 2025-10-30
Next Post: [Disclosure] Samsung Electronics (005930) – Decision on Disposal of Treasury Stock / 2025-10-30

Related Posts

[Disclosure] Hana Micron (067310) – Additional Listing (Exercise of Stock Options) / 2026-03-24 Semiconductors
[Disclosure] Celltrion (068270) – Additional Listing (Bonus Issue) / 2026-06-25 Disclosures
[Disclosure] SK square(402340) – Relisting due to Modification (Retirement of Shares) / 2025-12-12 Semiconductors
[Disclosure] Hanwha Aerospace (012450) to Hold Q4 2024 Investor Relations (IR) Meeting on February 10, 2025 Disclosures
[Disclosure] SK Square (402340) – Modification of Listing / 2025-04-23 Semiconductors
[Disclosure] Samsung Biologics (207940) – (Correction) Contract Signings for Supply and Sales / 2026-06-09 Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026
  • [Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] ALTEOGEN (196170) – Market Measures on Stock Futures and Options (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] Celltrion (068270) – CT-P44 (Darzalex Biosimilar) Korea Phase 3 Clinical Trial Plan Amendment Application / 2026-08-03August 3, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme